Infrared stability of global symmetries

We study the infrared stability of global symmetries. It is shown that small orthogonal groups O(N) (N < 4) are infrared attractive, while their direct products are unstable. We also discuss the stability of simple supersymmetric models and the role of auxiliary fields.     

Amide conformational switching induced by protonation of aromatic substituent

[reaction: see text] Introduction of an electron-withdrawing group on the aromatic ring of N-methylacetanilide decreased the ratio of the cis conformer, and the ratio correlates well with the Hammett sigma values of the substituents. These steric properties can be applied to achieve amide conformational switching by protonation at the aromatic substituent of 4-[bis(dimethylamino)]-N-methylacetanilide or N-[p-(dimethylamino)phenyl]-N-phenylacetamide.     

Ultramikroskopische Beobachtung einer Temperaturkoagulation

Ohne Zusammenfassung     

Construction of anomalously bent biphenyl structure using conformational properties of calix[4]amide

C_2v-symmetrical cyclic tetramers of aromatic amides were simply synthesized in moderate yield by condensation reaction of N,N′-dimethyl-1,3-phenylenediamine and isophthalic acid derivatives using dichlorotriphenylphosphorane. The calix[4]amides exist in 1,3-alternate structure with cis conformation of tertiary aromatic amides, which were shown to be a versatile scaffold leading to a bowl-shaped macrocyclic compound possessing a anomalously strained structure, a bent hinge angle between two aromatic ring planes of biphenyl moiety, via an intramolecular ligation reaction.     

Thiazolidinediones with thyroid hormone receptor agonistic activity.

Several thiazolidinedione derivatives (3-7) were designed and synthesized as candidate thyromimetic drugs. Among them, the dihydrogenated compounds, such as 5-2-[[4-(3-tert-butyl-4-hydroxyphenyl)oxy-3,5-diiodophenyl] ethyl]-2,4-thiazolidinedione (6b) and its 3-isopropyl analog (7b), exhibited potent thyroid hormone receptor alpha 1 (TR alpha 1) activation activity.     

Synthesis and evaluation of novel pyrimido-acridone, -phenoxadine, and -carbazole as topoisomerase II inhibitors

As part of a series of studies to discover new topoisomerase II inhibitors, novel pyrimidoacridones, pyrimidophenoxadines, and pyrimidocarbazoles were synthesized, and in vitro and in vivo antitumor activities and DNA-protein and/or DNA-topoisomerase II cross-linking activity as an indicator of topoisomerase II-DNA cleavable complex formation were evaluated. The pyrimidocarbazoles possessed high in vitro and in vivo potencies. Compound 26 (ER-37326), 8-acetyl-2-[2-(dimethylamino)ethyl]-1H-pyrimido[5,6,1-jk]carbazole-1,3(2H)-dione, showed in vitro growth inhibitory activity with respective IC(50) values of 0.049 microM and 0.35 microM against mouse leukemia P388 and human oral cancer KB. In vivo, this compound inhibited the tumor growth of mouse sarcoma M5076 implanted into mice with T/C values of 42% and 13% at 3.13 and 6.25 mg/kg/d respectively without significantly affecting the body weight. In addition, compound 26 (ER-37326) increased the formation of DNA-topoisomerase II cross-linking in P388 cells.     

A platinum-ruthenium dinuclear complex bridged by bis(terpyridyl)xanthene

4,5-Bis(terpyridyl)-2,7-di-tert-butyl-9,9-dimethylxanthene (btpyxa) was prepared to serve as a new bridging ligand via Suzuki coupling of terpyridin-4'-yl triflate and 2,7-di-tert-butyl-9,9-dimethylxanthene-4,5-diboronic acid. The reaction of btpyxa with either 1 equiv or an excess of PtCl(2)(cod) (cod = 1,5-cyclooctadiene) followed by anion exchange afforded mono- and dinuclear platinum complexes [(PtCl)(btpyxa)](PF(6)) ([1](PF(6))) and [(PtCl)(2)(btpyxa)](PF(6))(2) ([2](PF(6))(2)), respectively. The X-ray crystallography of [1](PF(6)).CHCl(3) revealed that the two terpyridine units in the ligand are nearly parallel to each other. The heterodinuclear complex [(PtCl)[Ru((t)Bu(2)SQ)(dmso)](btpyxa)](PF(6))(2) ([4](PF(6))(2)) (dmso = dimethyl sulfoxide; (t)Bu(2)SQ = 3,5-di-tert-butyl-1,2-benzosemiquinone) and the monoruthenium complex [Ru((t)Bu(2)SQ)(dmso)(trpy)](PF(6)) ([5](PF(6))) (trpy = 2,2':6',2' '-terpyridine) were also synthesized. The CV of [2](2+) suggests possible electronic interaction between the two Pt(trpy) groups, whereas such an electronic interaction was not suggested by the CV of [4](2+) between Pt(trpy) and Ru((t)Bu(2)SQ) frameworks.